Interferon regulatory factors in immune cell development and host response to infections

Interferons: Characterization, Mechanism of Action and Clinical Applications

Volumn , Issue , 2012, Pages 1-66

  Battistini, Angela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884263305     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (454)

1. Abdollahi, A; Lord, KA; Hoffman-Liebermann, B; Liebermann, DA. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 1991, 2: 401-407.
2. Ahmad, H; Gubbels, R; Ehlers, E; Meyer, F; Waterbury, T; Lin, R; and Zhang, L. Kaposi Sarcoma-associated Herpes virus Degrades Cellular Toll-Interleukin-1 Receptor Domain-containing Adaptor-inducing β-Interferon (TRIF). J. Biol. Chem. 2011, 286:7865-7872.
3. Ahyi, AN; Chang, HC; Dent, AL; Nutt, SL; Kaplan, MH. IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. J. Immunol. 2009, 183:1598-606.
4. Akira, S; Uematsu, S; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
5. Alexopoulou, L; Holt AC; Medzhitov, R; Flavel, RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
6. Aliberti, J; Schulz, O; Pennington, DJ; Tsujimura, H; Reis e Sousa, C; Ozato, K; Sher, A. Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells. Blood 2003, 101:305-310.
7. Alter-Koltunoff, M; Ehrlich, S; Dror, N; Azriel, A; Eilers, M; Hauser, H; Bowen, H; Barton, CH; Tamura, T; Ozato, K; Levi, BZ. Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1. J. Biol. Chem. 2003, 278:44025-44032.
8. Andersen, J; VanScoy, S; Cheng, TF; Gomez, D; Reich, NC. IRF-3-dependent and augmented target genes during viral infection. Genes Immunol. 2008, 9:168-175.
9. Andrejeva, J; Childs, KS; Young, DF; Carlos, TS; Stock, N; Goodbourn, S; Randall, RE. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 2004, 101:17264-17269.
10. Ardavin, C. Origin, precursors and differentiation of mouse dendritic cells. Nat. Rev. Immunol. 2003, 3:582-590.
11. Au, WC; Moore, PA; Lowther, W; Juang, YT; Pitha, PM. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 1995, 92:11657-11661.
12. Au, WC; Moore, PA; LaFleur, DW; Tombal, B; Pitha, PM. Characterization of the interferon J. Biol. Chem. 1998, 273:29210-29217.
13. Au, WC; Yeow, WS; Pitha, PM. Analysis of functional domains of interferon Virology 2001, 280:273-282.
14. Bailey, CM; Abbott, DE; Margaryan, NV; Khalkhali-Ellis, Z; Hendrix, MJ. Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle dependent manner. Mol. Cell. Biol. 2008a, 28:2235-2243.
15. Bailey, CM; Hendrix, MJ. IRF6 in development and disease: a mediator of quiescence and differentiation. Cell Cycle 2008b, 7:1925-1930.
16. Balkhi, MY; Fitzgerald, KA; Pitha, PM. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol. Cell Biol, 2008, 28:7296-7308.
17. Balkhi, MY; Fitzgerald, KA; Pitha, PM. IKKalpha negatively regulates IRF-5 function in a MyD88-TRAF6 pathway. Cell Signal. 2010, 22:117-127.
18. Barber, GN. Cytoplasmic DNA innate immune pathways. Immunol. Rev. 2011, 243:99-108.
19. Barnes, BJ; Moore, PA; Pitha, PM. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 2001, 276: 23382-23390.
20. Barnes, B; Lubyova, B; Pitha, PM. On the role of IRF in host
21. Barnes, BJ; Kellum, MJ; Field, AE; Pitha, PM. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell Biol. 2002, 22:5721-5740.
22. Barnes, BJ; Field, AE; Pitha-Rowe, PM. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J. Biol. Chem. 2003, 278:16630-16641.
23. Barnes, BJ; Richards, J; Mancl, M; Hanash, S; Beretta, L; Pitha, PM. Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J. Biol. Chem. 2004, 279: 45194-45207.
24. Barro, M; Patton, JT. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA, 2005; 102: 4114-4119.
25. Barro, M; Patton, JT. Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J. Virol., 2007; 81: 4473-4481.
26. Basler, CF; Amarasinghe, GK. Evasion of interferon J. Interferon Cytokine. Res. 2009, 29: 511-520.
27. Battistini, A. Interferon regulatory factors in hematopoietic cell differentiation and immune regulation. J. Interferon Cytokine Res. 2009, 29:765-780.
28. Bauhofer, O; Summerfield, A; Sakoda, Y; Tratschin, JD; Hofmann, MA; Ruggli, N. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomaldegradation. J. Virol. 2007, 81: 3087-3096.
29. Belgnaoui, SM; Paz, S; Hiscott, J. Orchestrating the interferon Curr. Opin. Immunol, 2011; 23: 564-572.
30. Belz, GT; Nutt, SL. Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 2012, 12:101-113. doi: 10.1038/nri3149.
31. Bettermann, K; Benesch, M; Weis, S; Haybaeck, J. SUMOylation in carcinogenesis. Cancer Lett. 2012, 316: 113-125.
32. Bi, X; Yang, L; Mancl, ME; Barnes, BJ. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction. J. Interferon Cytokine Res. 2011, 31:373-382.
33. Bibeau-Poirier, A; Gravel, SP; Clement, JF; Rolland, S; Rodier, G; Coulombe, P; Hiscott, J; Grandvaux, N; Meloche, S; Servant, MJ. Involvement of the IκB kinase (IKK)-related kinasesTank-binding kinase 1/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation. J. Immunol. 2006, 177: 5059-5067.
34. Birnbaum, MJ; van Zundert, B; Vaughan, PS; Whitmarsh AJ; van Wijnen, AJ; Davis, RJ; Stein, GS; Stein, JL. Phosphorylation of the oncogenic transcription factor interferon regulatory factor 2 (IRF2) in vitro and in vivo. J. Cell Biochem. 1997, 66: 175-183.
35. Bluyssen, AR; Durbin, JE; Levy, DE. ISGF3 gamma p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 1996, 7:11-17.
36. Botti, E; Spallone, G; Moretti, F; Marinari, B; Pinetti, V; Galanti, S; De Meo, PD; De Nicola, F; Ganci, F; Castrignanò, T; Pesole, G; Chimenti, S; Guerrini, L; Fanciulli, M; Blandino, G; Karin, M; Costanzo, A. Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc. Natl. Acad. Sci. USA 2011, 16:108:13710-13715.
37. Brass, AL; Kehrli, E; Eisenbeis, CF; Storb, U; Singh, H. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 1996, 10: 2335-2347.
38. Brass, AL; Zhu, AQ; Singh, H. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J. 1999, 18: 977-991.
39. Brüstle, A; Heink, S; Huber, M; Rosenplanter, C; Stadelmann, C; Yu, P; Arpaia, E; Mak, TW; Kamradt, T; Lohoff, M. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007, 8:958-966.
40. Brzózka, K; Finke, S; Conzelmann, KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 2005, 79:7673-7681.
41. Burysek, L; Yeow, WS; Lubyova, B; Kellum, M; Schafer, SL; Huang, YQ; Pitha, PM. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 1999, 73:7334-7342.
42. Cai, Z; Shi, Z; Sanchez, A; Zhang, T; Liu, M; Yang, J; Wang, F; Zhang, D. Transcriptional regulation of Tlr11 gene expression in epithelial cells. J. Biol. Chem. 2009, 284:33088-33096.
43. Caillaud, A; Prakash, A; Smith, E; Masumi, A; Hovanessian, AG; Levy, DE; and Marie, IJ. Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding. J. Biol. Chem. 2002, 277: 49417-49421.
44. Caillaud, A; Hovanessian, AG; Levy, DE; Marie, IJ. Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7. J. Biol. Chem. 2005, 280: 17671-17677.
45. Castaldello, A; Sgarbanti, M; Marsili, G; Brocca-Cofano, E; Remoli, AL; Caputo, A; Battistini, A. Interferon Regulatory Factor-1 Acts as a Powerful Adjuvant in tat DNA Based Vaccination. J. Cell. Physiol. 2010, 224: 702-709.
46. Cattoretti, G; Shaknovich, R; Smith, PM; Jäck, HM; Murty, VV; Alobeid, B. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J. Immunol. 2006, 177:6930-6939.
47. Chae, M; Kim, K; Park, MS; Jang, IS; Seo, T; Kim, DM; Kim, IC; Lee, H; Park, J. IRF-2 regulates NF-kappaB activity by modulating the subcellular localization of NF-kappaB. Biochem. Biophys. Res. Commun. 2008, 370: 519-524.
48. Chang, CH; Hammer, J; Loh, JE; Fodor, WL; Flavell, RA. The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 1992, 35:378-384.
49. Chang, TH; Kubota, T; Matsuoka, M; Jones, S; Bradfute, SB; Bray, M; Ozato, K. Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. PLoS Pathog. 2009, 5: e1000493.
50. Chen, Q; Yang, W; Gupta, S; Biswas, P; Smith, P; Bhagat, G; Pernis, AB. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 2008, 29:899-911.
51. Chen, W; Lam, SS; Srinath, H; Jiang, Z; Correia, JJ; SchiVer, CA; Fitzgerald, KA; Lin, K; Royer, WE Jr. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 2008, 15:1213-1220.
52. Chen, W; Royer WE Jr. Structural insights into interferon regulatory factor activation. Cell Signal. 2010, 22:883-887.
53. Cheng, TF; Brzostek, S; Ando, O; Van Scoy, S; Kumar, KP; Reich, NC. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J. Immunol. 2006, 176: 7462-7470.
54. Childs, KS; Goodbourn, S. Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. Nucleic Acids Res. 2003, 31: 3016-3026.
55. Ciccaglione, AR; Stellacci, E; Marcantonio, C; Muto, V; Equestre, M; Marsili, G; Rapicetta, M; Battistini, A. Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J. Virol. 2007, 81:202-214.
56. Cisse, B; Caton, ML; Lehner, M; Maeda, T; Scheu, S; Locksley, R; Holmberg, D; Zweier, C; den Hollander, NS; Kant, SG; Holter, W; Rauch, A; Zhuang, Y; Reizis, B. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135:37-48.
57. Clement, JF; Bibeau-Poirier, A; Gravel, SP; Grandvaux, N; Bonneil, E; Thibault, P; Meloche, S; Servant, M.J. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J. Virol. 2008, 82: 3984.
58. Cloutier, N; Flamand, L. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. J. Biol. Chem. 2010, 285:7208-7221.
59. Coberley, CR; Kohler, JJ; Brown, JN; Oshier, JT; Baker, HV; Popp, MP; Sleasman, JW; Goodenow, MM. Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1. J. Virol. 2004, 78:11477-11486.
60. Coccia, EM; Passini, N; Battistini, A; Sinigaglia, F; Rogge, L. Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells. J. Biol. Chem. 1999a, 274:6698-6703.
61. Coccia, EM; Del Russo, N; Stellacci, E; Orsatti, R; Benedetti, E; Marziali, G; Hiscott, J; Battistini, A. Activation and Repression of the 2-5A Synthetase and p21 Gene Promoters by IRF-1 and IRF-2. Oncogene 1999b, 18: 2129-2137.
62. Coccia, EM; Stellacci, E; Marziali, G; Weiss, G; Battistini A. IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int. Immunol. 2000,12:977-985.
63. Coccia, EM; Stellacci, E; Valtieri, M; Masella, B; Feccia, T; Marziali, G; Hiscott, J; Testa, U; Peschle, C, Battistini, A. Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation. Biochem J. 2001, 360:285-294.
64. Cohen, H; Azriel, A; Cohen, T; Meraro, D; Hashmueli, S; Bech-Otschir, D; Kraft, R; Dubiel, W; Levi, BZ. Interaction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15). A possible link between interferon regulatory factor signaling and the COP9/signalosome. J. Biol. Chem. 2000, 275:39081-39089.
65. Colonna, M; Trinchieri, G; Liu YJ. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5: 1219-1226.
66. Conrady, CD; Zheng, M; Fitzgerald, KA; Liu, C; Carr, DJ. Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16. Mucosal. Immunol. 2012, doi: 10.1038/mi.2011.63.
67. Cunningham, C; Barnard, S; Blackbourn, DJ; Davison, AJ. Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J. Gen. Virol. 2003, 84:1471-1483.
68. D'Cunha, J; Knight, E Jr; Haas, AL; Truitt, RL; Borden, EC. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. USA 1996, 93:211-215.
69. Darnell, JE Jr; Kerr, IM; Stark, GR. Jak.-STAT pathways Science 1994, 264:1415-1421.
70. Decker, T; Müller, M; Stockinger, S. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 2005, 5:675-687.
71. Desterro, JM; Rodriguez MS; Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell. 1998, 2: 233-239.
72. Dietrich, N; Lienenklaus, S; Weiss, S; Gekara, NO. Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS One. 2010, 5:e10250.
73. DiPerna, G; Stack, J; Bowie, AG; Boyd,A; Kotwal, G; Zhang, Z; Arvikar, S; Latz, E; Fitzgerald, KA; Marshall, WL. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J. Biol. Chem. 2004, 279: 36570-36578.
74. Dissemond, J; Haberer, D; Franckson, T; Hillen, U. The Van der Woude syndrome: a case report and review of the literature. J. Eur. Acad. Dermatol. Venereol. 2004, 18:611-613.
75. Dixit, E; Boulant, S; Zhang, Y; Lee, AS; Odendall, C; Shum, B; Hacohen, N; Chen, ZJ; Whelan, SP; Fransen, M; Nibert, ML; Superti-Furga, G; Kagan, JC. Peroxisomes are signaling platforms for antiviral innate immunity Cell 2010, 141: 668-681.
76. Doehle, BP; Hladik, F; McNevin, JP; McElrath, MJ; Gale, M Jr. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J. Virol. 2009, 83:10395-10405.
77. Doyle, S; Vaidya, S; O'Connell, R; Dadgostar, H; Dempsey, P; Wu, T; Rao, G; Sun, R; Haberland, M; Modlin, R; Cheng, G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17:251-263.
78. Drew, PD; Franzoso, G; Carlson, LM; Biddison, WE; Siebenlist, U; Ozato, K. Interferon regulatory factor-2 physically interacts with NF-kappa B in vitro and inhibits NF-kappa B induction of major histocompatibility class I and beta 2-microglobulin gene expression in transfected human neuroblastoma cells. J. Neuroimmunol. 1995, 63:157-162.
79. Eisenbeis, CF; Singh, H; Storb, U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 1995, 9:1377-1387.
80. Eklund, EA; Jalava A; Kakar R. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91phox expression. J. Biol. Chem. 1998, 273:13957-13965.
81. Elco, CP; Guenther, JM; Williams, BRG; Sen, GC. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J. Virol. 2005, 79:3920-3929.
82. Elser, B; Lohoff, M; Kock, S; Giaisi, M; Kirchhoff, S; Krammer, PH; Li-Weber, M. IFN Immunity 2002, 17:703-712.
83. Falini, B; Fizzotti, M; Pucciarini, A; Bigerna, B; MaraWoti, T; Gambacorta, M; Pacini, R; Alunni, C; Natali-Tanci, L; Ugolini, B; Sebastiani, C; Cattoretti, G; Pileri, S; Dalla-Favera, R; Stein, H. A monoclonal antibody (MUM1p) detects expression ofthe MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 2000, 95:2084-2092.
84. Farrow, MA; Kim, EY; Wolinsky, SM; Sheehy, AM. NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G. J. Biol. Chem. 2011, 286:2567-2577.
85. Feng, J; Wang, H; Shin, D-M; Masiuk, M; Qi, C-F; Morse, HC. IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J. Immunol. 2011, 186: 1458-1466.
86. Fitzgerald, KA; McWhirter, SM; Faia, KL; Rowe, DC; Latz, E; Golenbock, DT; Coyle, AJ; Liao, SM; Maniatis, T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003a, 4:491-496.
87. Fitzgerald, KA; Rowe, DC; Barnes, BJ; Caffrey, DR; Visintin, A; Latz, E; Monks, B; Pitha, PM; Golenbock, DT. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 2003b, 198:1043-1055.
88. Flandin, JF; Chano, F; Descoteaux, A. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages. Eur. J. Immunol. 2006, 36:411-420.
89. Fragale, A; Gabriele, L: Stellacci, E; Borghi, P; Perrotti, E; Ilari, R; Lanciotti, A; Remoli, AL; Venditti, M; Belardelli, F; Battistini, A. IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. J. Immunol. 2008, 181:1673-1682.
90. Fragale, A; Stellacci, E; Ilari, R; Remoli, AL; Lanciotti, A; Perrotti, E; Shytaj, I; Orsatti, R; Lawrence, HR; Lawrence, NJ; Wu, J; Rehli, M; Ozato, K; Battistini, A. Critical role of IRF-8 in negative regulation of TLR3 J. Immunol. 2011, 186:1951-1962.
91. Fredericksen, BL; Gale, M; Jr. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J. Virol. 2006, 80:2913-2923.
92. Fu, XY; Kessler DS; Veals SA; Levy DE; Darnell JE; Jr. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA 1990, 87: 8555-8559.
93. Fujita, T; Sakakibara, J; Sudo, Y; Miyamoto, M; Kimura, Y; Taniguchi, T. Evidence for a nuclear factor(s), IRF-1, mediating induction EMBO J. 1988, 7:3397-3405.
94. Fujita, T; Kimura, Y; Miyamoto, M; Barsoumian, EL; Taniguchi, T. Induction of endogenous IFN Nature. 1989a, 337:270-272.
95. Fujita, T; Reis, LF; Watanabe, N; Kimura, Y; Taniguchi, T; Vilcek, J. Induction of the transcription Proc. Natl. Acad. Sci. USA. 1989b, 86:9936-9940.
96. Furrie, E; Macfarlane, S; Thomson, G; Macfarlane, GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005, 115:565-574.
97. Gabriele, L; Fragale, A; Borghi, P; Sestili, P; Stellacci, E; Venditti, M; Schiavoni, G; Sanchez, M; Belardelli, F; Battistini, A. IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. J. Leukoc. Biol. 2006, 80:1500-1511.
98. Galon, J; Sudarshan, C; Ito, S; Finbloom, D; O'Shea, JJ. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J. Immunol. 1999, 162:7256-7262.
99. Garcia-Dominguez, M; Reyes, JC. SUMO association with repressor complexes, emerging routes for transcriptional control. Biochim. Biophys. Acta 2009, 1789:451-459.
100. Garcia-Sastre, A. Mechanisms of inhibition of the host interferon a/ï-mediated antiviral responses by viruses. Microbes Infect. 2002; 4: 647-655.
101. Geiss, G; Jin, G; Guo, J; Bumgarner, R; Katze, MG; Sen, GC. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. (2001) 276, 30178-30182.
102. Ghoreschi, K; Laurence, A; Yang, XP; Hirahara, K; O'Shea, JJ. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Curr. Opin. Immunol. 2011, 23:702-706.
103. Ghosh, S; Hayden, MS. New regulators of NF-jB in inflammation. Nat. Rev. Immunol. 2008, 8: 837-848.
104. Giese, NA; Gabriele, L; Doherty, TM; Klinman, DM; Tadesse-Heath, L; Contursi, C; Epstein, SL; Morse, HC 3rd. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 1997, 186:1535-1546.
105. Gill, G. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr. Opin. Genet. Dev. 2003, 13:108-113.
106. Gill, G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 2005, 15:536-541.
107. Goubau, D; Romieu-Mourez, R; Solis, M; Hernandez, E; Mesplède, T; Lin, R; Leaman, D; Hiscott, J. Transcriptional re-programming of primary macrophages reveals distinct apoptotic and anti-tumoral functions of IRF-3 and IRF-7. Eur. J. Immunol. 2009, 39:527-540.
108. Graff, JW; Mitzel, DN; Weisend, CM; Flenniken, ML; Hardy, ME. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J. Virol 2.002, 76:9545-9550.
109. Graham, RR; Kozyrev, SV; Baechler, EC; Reddy, MV; Plenge, RM; Bauer, JW; Ortmann, WA; Koeuth, T; Gonzalez Escribano, MF; Pons-Estel, B; Petri, M; Daly, M; Gregersen, PK; Martin, J; Altshuler, D; Behrens, TW; Alarcon-Riquelme, ME. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 2006, 38:550-555.
110. Graham, RR; Kyogoku, C; Sigurdsson, S; Vlasova, IA; Davies, LR; Baechler, EC; Plenge, RM; Koeuth, T; Ortmann, WA; Hom, G; Bauer, JW; Gillett, C; Burtt, N; Cunninghame Graham, DS; Onofrio, R; Petri, M; Gunnarsson, I; Svenungsson, E; Rönnblom, L; Nordmark, G; Gregersen, PK; Moser, K; Gaffney, PM; Criswell, LA; Vyse, TJ; Syvänen, AC; Bohjanen, PR; Daly, MJ; Behrens, TW; Altshuler, D. Three functional variants of IFN Proc. Natl. Acad. Sci. USA 2007, 104:6758-6763.
111. Grandvaux, N; Servant, MJ; tenOever, B; Sen, GC; Balachandran, S; Barber, GN; Lin, R, Hiscott, J. Transcriptional profiling of interferon J. Virol. 2002, 76:5532-5539.
112. Guo, Z; Garg, S; Hill, KM; Jayashankar, L; Mooney, MR; Hoelscher, M; Katz, JM; Boss, JM; Sambhara, S. A distal regulatory region is required for constitutive and IFN-beta-induced expression of murine TLR9 gene. J. Immunol. 2005, 175:7407-7418.
113. Gupta, S; Jiang, M; Anthony, A; Pernis, AB. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 1999, 190:1837-1848.
114. Gururajan, M; Haga, CL; Das, S; Leu, CM; Hodson, D; Josson, S; Turner, M; Cooper, MD. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int Immunol. 2010, 22:583-592.
115. Hahn, AM; Huye, LE; Ning, S; Webster-Cyriaque, J: Pagano, JS. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 2005, 79:10040-10052.
116. Hambleton, S; Salem, S; Bustamante, J; Bigley, V; Boisson-Dupuis, S; Azevedo, J; Fortin, A; Haniffa, M; Ceron-Gutierrez, L; Bacon, CM; Menon, G; Trouillet, C; McDonald, D; Carey, P; Ginhoux, F; Alsina, L; Zumwalt, TJ; Kong, XF; Kumararatne, D; Butler, K; Hubeau, M; Feinberg, J; Cant, A; Abel, L; Chaussabel, D; Doffinger, R; Talesnik, E; Grumach, A; Duarte, A; Abarca, K; Moraes-Vasconcelos, D; Burk, D; Berghuis, A; Geissmann, F; Collin, M; Casanova, JL; Gros P. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 2011, 365:127-138.
117. Han, KJ; Jiang, L; Shu, HB. Regulation of IRF2 transcriptional activity by its sumoylation. Biochem. Biophys. Res. Commun. 2008, 372:772-778.
118. Harada, H; Fujita, T; Miyamoto, M; Kimura, Y; Maruyama, M; Furia, A; Miyata, T; Taniguchi, T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN Cell 1989, 58:729-739.
119. Harada, H; Kitagawa, M; Tanaka, N; Yamamoto, H; Harada, K; Ishihara, M; Taniguchi, T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993, 259:971-974.
120. Harada, H; Matsumoto, M; Sato, M; Kashiwazaki, Y; Kimura, T; Kitagawa, M; Yokochi, T; Tan, RS; Takasugi, T; Kadokawa, Y; Schindler, C; Schreiber, RD; Noguchi, S; Taniguchi, T. Regulation of IFN Genes. Cells. 1996, 1:995-1005.
121. Harada, H; Willison, K; Sakakibara, J; Miyamoto, M; Fujita, T; Taniguchi, T. Absence of the type I IFN Cell 1990, 3:303-312.
122. Harman, AN; Lai, J; Turville, S; Samarajiwa, S; Gray, L; Marsden, V; Mercier, S; Jones, K; Nasr, N; Rustagi, A; Cumming, H; Donaghy, H; Mak, J; Gale, M; jr, Churchill, M; Hertzog, P; Cunningham, AL. HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood 2011, 118: 298-308.
123. Hartman, AL; Bird, BH; Towner, JS; Antoniadou, ZA; Zaki, SR; Nichol, ST. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J. Virol. 2008, 82:2699-2704.
124. Hay, RT. SUMO: a history of modification. Mol. Cell. 2005, 18:1-12.
125. Heil, F; Hemmi, H., Hochrein, H; Ampenberger, F; Kirschning, C; Akira, S; Lipford, G; Wagner, H; Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303: 1526-1529.
126. Heinz, S., Haehnel, V; Karaghiosoff, M; Schwarzfischer, L; Muller, M; Krause, SW; Rehli, M. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J. Biol. Chem. 2003, 278:21502-21509.
127. Hemmi, H., Kaisho, T; Takeuchi, O; Sato, S; Sanjo, H; Hoshino, K; Horiuchi, T; Tomizawa, H; Takeda, K; Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3: 196-200.
128. Hemmi, H; Takeuchi, O; Kawai, T; Kaisho, T; Sato, S; Sanjo, H; Matsumoto, M; Hoshino, K; Wagner, H; Takeda K; Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
129. Hida, S; Ogasawara, K; Sato, K; Abe, M; Takayanagi, H; Yokochi, T; Sato, T; Hirose, S; Shirai, T; Taki, S; Taniguchi, T. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 2000, 13:643-655.
130. Hida, S; Tadachi, M; Saito, T; Taki, S. Negative control of basophil expansion by IRF-2 critical for the regulation of Th1/Th2 balance. Blood 2005, 106:2011-2017.
131. Higgs, R; Jefferies, CA. Targeting IRFs by ubiquitination: regulating antiviral responses. Biochem. Soc. Trans. 2008, 36:453-458.
132. Higgs, R; Lazzari, E; Wynne, C; Ní Gabhann, J; Espinosa, A; Wahren-Herlenius, M; Jefferies, CA. Self protection from anti-viral responses Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors. PLoS One 2010, 5: e11776.
133. Hilton, L; Moganeradj, K; Zhang, G; Chen, YH; Randall, RE; McCauley, JW; Goodbourn, S. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J. Virol. 2006, 80:11723-11732.
134. Hiscott, J. Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 2007a, 18:483-490.
135. Hiscott, J. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 2007b, 282:15325-15329.
136. Hochrein, H; Schlatter, B; O'Keeffe, M; Wagner, C; Schmitz, F; Schiemann, M; Bauer, S; Suter, M; Wagner, H. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 2004, 101:11416-11421.
137. Holtschke, T; Löhler, J; Kanno, Y; Fehr, T; Giese, N; Rosenbauer, F; Lou, J; Knobeloch, KP; Gabriele, L; Waring, JF; Bachmann, MF; Zinkernagel, RM; Morse, HC 3rd; Ozato, K; Horak, I. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996, 87:307-317.
138. Honda, K; Mizutani, T; Taniguchi, T. Negative regulation of IFN-alpha/beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc. Natl. Acad. Sci. USA 2004, 101:2416-2421.
139. Honda, K; Yanai, H; Mizutani, T; Negishi, H; Shimada, N; Suzuki, N; Ohba, Y; Takaoka, A; Yeh, WC; Taniguchi, T. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004, 101:15416-15421.
140. Honda, K; Yanai, H; Negishi, H; Asagiri, M; Sato, M; Mizutani, T; Shimada, N; Ohba, Y; Takaoka, A; Yoshida, N; Taniguchi, T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005a, 434:772-777.
141. Honda, K; Ohba, Y; Yanai, H; Negishi, H; Mizutani, T; Takaoka, A; Taya, C; Taniguchi, T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 2005b, 434:1035-1040.
142. Honda, K; Taniguchi, T. IRFs: master regulators of signaling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 2006a, 6:644-658.
143. Honda, K; Takaoka, A; Taniguchi, T. Type I interferon Immunity. 2006b, 25:349-360.
144. Honma, K; Kimura, D; Tominaga, N; Miyakoda, M; Matsuyama, T; Yui, K. Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines Proc. Natl. Acad. Sci. USA. 2008, 105:15890-15895.
145. Honma, K; Udono, H; Kohno, T; Yamamoto, K; Ogawa, A; Takemori, T; Kumatori, A; Suzuki, S; Matsuyama, T; Yui, K. Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS. Proc. Natl. Acad. Sci. USA 2005, 102:16001-16006.
146. Hornung, V; Ellegast, J; Kim, S; Brzozka, K; Jung, A; Kato, H; Poeck, H; Akira, S; Conzelmann, KK; Schlee, M; Endres, S; Hartmann, G. 50-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
147. Hoshino, K; Sugiyama, T; Matsumoto, M; Tanaka, T; Saito, M; Hemmi, H; Ohara, O; Akira, S; Kaisho, T. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature. 2006, 440:949-953.
148. Hoshino, T; Sugiyama, M; Matsumoto, T; Tanaka, M; Saito, H; Hemmi, O; Ohara, S; Akira, T; Kaisho, I. kappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 2006, 440: 949-953.
149. Hu, CM; Jang, SY; Fanzo, JC; Pernis, AB. Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 2002, 277:49238-49246.
150. Huang, W; Horvath, E; Eklund, EA. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells. J. Biol. Chem. 2007, 282:6629-6643.
151. Huang, W; Saberwal, G; Horvath, E; Zhu, C; Lindsey, S; Eklund, EA. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine Mol. Cell. Biol. 2006, 26:6311-6332.
152. Huye, LE; Ning, S; Kelliher, M; Pagano, JS. Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol. Cell. Biol. 2007, 27:2910-2918.
153. Hwang, S; Kim, KS; Flano, E; Wu, TT; Tong, LM; Park, AN; Song, MJ; Sanchez, DJ; O'Connell, RM; Cheng, G; Sun. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe 2009, 5:166-178.
154. Ichikawa, E; Hida, S; Omatsu, Y; Shimoyama, S; Takahara, K; Miyagawa, S; Inaba, K; Taki, S. Defective development of splenic and epidermal CD4 + dendritic cells in mice deWcient for IFN regulatory factor-2. Proc. Natl. Acad. Sci. USA 2004, 101:3909-3914.
155. Ingraham, CR; Kinoshita, A; Kondo, S; Yang, B; Sajan, S; Trout, KJ; Malik, MI; Dunnwald, M; Goudy, SL; Lovett, M; Murray, JC; Schutte, BC. Abnormal skin Nat. Genet. 2006 38:1335-1340.
156. Inohara, N; Nunez, G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 2003, 3:371-382.
157. Ishii, KJ; Coban, C; Kato, H; Takahashi, K; Torii, Y; Takeshita, F; Ludwig, H; Sutter, G; Suzuki, K; Hemmi, H; Sato, S; Yamamoto, M; Uematsu, S; Kawai, T; Takeuchi, O; Akira, S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 2006, 7:40-48.
158. Ishikawa, H; Barber, GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
159. Itoh, S; Harada, H; Fujita, T; Mimura, T; Taniguchi, T. Sequence of a cDNA Nucleic Acids Res. 1989, 17:8372.
160. Ivanov, II; McKenzie, BS; Zhou, L; Tadokoro, CE; Lepelley, A; Lafaille, JJ; Cua, DJ;Littman, DR. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
161. Izaguirre, A; Barnes, BJ; Amrute, S; Yeow, WS; Megjugorac, N; Dai, J; Feng, D; Chung, E; Pitha, PM; Fitzgerald-Bocarsly, P. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 2003, 74:1125-1138.
162. Jesse, TL; LaChance, R; Iademarco, MF; Dean, DC. Interferon regulatory factor-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1. J. Cell Biol. 1998, 140:1265-1276.
163. Johnson, ES. Protein modification by SUMO, Annu. Rev. Biochem. 2004, 73:355-382.
164. Johnson, K; Hashimshony, T; Sawai, CM; Pongubala, JM; Skok, JA; Aifantis, I; Singh, H. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 2008, 28:335-345.
165. Joo, CH; Shin, YC; Gack, M; Wu, L; Levy, D; Jung, JU. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 2007, 81:8282-8292.
166. Juang, YT; Lowther, W; Kellum, M; Au, WC; Lin, R; Hiscott, J; Pitha, PM. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 1998, 95:9837-9842.
167. Kaku, H; Rothstein, TL. Fas apoptosis inhibitory molecule expression in B cells is regulated through IRF4 in a feed-forward mechanism. J. Immunol. 2009, 183:5575-5581.
168. Kanazawa, N; Kurosaki, M; Sakamoto, N; Enomoto, N; Itsui, Y; Yamashiro, T; Tanabe, Y; Maekawa, S; Nakagawa, M; Chen, CH; Kakinuma, S; Oshima, S; Nakamura T; Kato T; Wakita T; Watanabe M. Regulation of hepatitis C virus replication by interferon regulatory factor 1. J. Virol. 2004, 78:9713-9720.
169. Kanneganti, TD; Lamkanfi, M; Nunez, G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007, 27:549-559.
170. Kanneganti, TD. Central roles of NLRs and inflammasomes in viral infection Nat. Rev. Immunol. 2010, 10:688-698.
171. Kanno, Y; Levi, BZ; Tamura, T; Ozato, K. Immune cell specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J. Interferon Cytokine. Res. 2005, 25:770-779.
172. Kano, S; Sato, K; Morishita, Y; Vollstedt, S; Kim, S; Bishop, K; Honda, K; Kubo, M; Taniguchi, T. The contribution of transcription factor IRF-1 to the interferon-gamma-interleukin 12 signaling axis and Th1 versus TH-17 differentiation of CD4+ T cells. Nat. Immunol. 2008, 9:9-10.
173. Karin, M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006, 441:431-436.
174. Kato, H; Sato, S; Yoneyama, M; Yamamoto, M; Uematsu, S; Matsui, K; Tsujimura, T; Takeda, K; Fujita, T; Takeuchi, O; Akira, S. Cell type-specific involvement of RIG-I in antiviral response. Immunity. 2005, 23:19-28.
175. Kato, H; Takeuchi, O; Sato, S; Yoneyama, M; Yamamoto, M; Matsui, K; Uematsu, S; Jung, A; Kawai, T; Ishii, KJ; Yamaguchi, O;, Otsu, K; Tsujimura, T;, Koh, CS; Reis e Sousa, C;, Matsuura, Y; Fujita, T; Akira, S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 2006, 441:101-105.
176. Katze, MG; He, Y; Gale, M Jr. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002; 2: 675-687.
177. Kautz, B; Kakar, R; David, E; Eklund EA. SHP1 protein-tyrosine phosphatase inhibits gp91PHOX and p67PHOX expression by inhibiting interaction of PU.1, IRF1, interferon consensus sequence-binding protein, and CREB-binding protein with homologous cis elements in the CYBB and NCF2 genes. J. Biol. Chem. 2001, 276:37868-37878.
178. Kawai, T; Takeuchi, O; Fujita, T; Inoue, J; Mühlradt, PF; Sato, S; Hoshino, K; Akira, S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167:5887-5894.
179. Kawai, T; Sato, S; Ishii, KJ; Coban, C; Hemmi, H; Yamamoto, M; Terai, K; Matsuda, M; Inoue, J; Uematsu, S; Takeuchi, O; Akira, S. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004, 5:1061-1068.
180. Kawai, T; Takahashi, K; Sato, S; Coban, C; Kumar, H; Kato, H; Ishii, KJ; Takeuchi, O; Akira S. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol. 2005, 6:981-988.
181. Kawai, T; Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
182. Kawai, T; Akira, S. Toll-like receptors and their cross-talk with other innate receptors in infection and immunity. Immunity. 2011, 34:637-650.
183. Kawakami, T; Matsumoto, M; Sato, M; Harada, H; Taniguchi, T; Kitagawa, M. Possible involvement of the transcription FEBS Lett. 1995, 358:225-229.
184. Kim, EJ; Park, JS; Um, SJ. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1. Biochem. Biophys. Res. Commun. 2008, 377:952-956.
185. Kim, YM; Im, JY; Han, SH; Kang, HS; Choi, I. IFN-gamma up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages. J. Immunol. 2000, 165, 3198-3205.
186. Kimura, T; Nakayama, K; Penninger, J; Kitagawa, M; Harada, H; Matsuyama, T; Tanaka, N; Kamijo, R; Vilcek, J; Mak, TW; et al. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 1994, 264:1921-1924.
187. Kimura, T; Kadokawa, Y; Harada, H; Matsumoto, M; Sato, M; Kashiwazaki, Y; Tarutani, M; Tan, RS; Takasugi, T; Matsuyama, T; Mak, TW; Noguchi, S; Taniguchi, T. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon Genes Cells. 1996, 1:115-124.
188. Kitagawa, Y; Yamaguchi, M; Zhou, M; Komatsu, T; Nishio, M; Sugiyama, T; Takeuchi, K; Itoh, M; Gotoh, B. A tryptophan-rich motif in the human parainfluenza virus type 2 V protein is critical for the blockade of toll-like receptor 7 (TLR7)-and TLR9-dependent signaling. J. Virol. 2011, 85: 4606-4611.
189. Klein, U; Casola, S; Cattoretti, G; Shen, Q; Lia, M; Mo, T; Ludwig, T; Rajewsky, K; Dalla-Favera, R. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 2006, 7:773-782.
190. Kollet, JI; Petro, TM. IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol. Immunol. 2006, 43:623-633.
191. Kondo, S; Schutte, BC; Richardson, RJ; Bjork, BC; Knight, AS; Watanabe, Y; Howard, E; de Lima, RL; Daack-Hirsch, S; Sander, A; McDonald-McGinn, DM; Zackai, EH; Lammer, EJ; Aylsworth, AS; Ardinger, HH; Lidral, AC; Pober, BR; Moreno, L; Arcos-Burgos, M; Valencia; Houdayer, C; Bahuau, M; Moretti-Ferreira, D; Richieri-Costa, A; Dixon, MJ; Murray, JC. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat. Genet. 2002 32:285-289.
192. Kondo, M; Wagers, AJ; Manz, MG; Prohaska, SS; Scherer, DC; Beilhack, GF; Shizuru, JA; Weissman, IL. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 2003, 21: 759-806.
193. Kong, HJ; Anderson, DE; Lee, CH; Jang, MK; Tamura, T; Tailor, P; Cho, HK; Cheong, J; Xiong, H; Morse, III HC; Ozato, K. Cutting edge: autoantigen ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression inmacrophages. J. Immunol. 2007, 179: 26-30.
194. Konieczna, I; Horvath, E; Wang, H; Lindsey, S; Saberwal, G; Bei, L; Huang, W; Platanias, L; Eklund, EA. Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia. J. Clin. Invest. 2008, 118:853-867.
195. Kopecky-Bromberg, SA; Martínez-Sobrido, L; Frieman, M; Baric, RA; Palese, P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007 81:548-557.
196. Kozyrev, SV; Alarcon-Riquelme, ME. The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity. 2007, 40:591-601.
197. Kraus, TA; Lau, JF; Parisien, JP; Horvath, CM. A hybrid IRF9-STAT2 protein recapitulates interferon-stimulated gene expression and antiviral response. J. Biol. Chem. 2003 278:13033-13038.
198. Krausgruber, T; Saliba, D; Ryzhakov, G; Lanfrancotti, A; Blazek, K; Udalova, IA. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 2010, 115:4421-4430.
199. Kröger, A; Köster, M; Schroeder, K; Hauser, H; Mueller, PP. Activities of IRF-1. J. Interferon Cytokine. Res. 2002, 22:5-14.
200. Kubota, T; Matsuoka, M; Chang, TH; Tailor, P; Sasaki, T; Tashiro, M; Kato, A; Ozato K. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J. Biol. Chem. 2008, 283: 25660-25670.
201. Kumar, KP; McBride, KM; Weaver, BK; Dingwall, C; Reich, NC. Regulated nuclear-cytoplasmic localization
202. Kyogoku, C; Tsuchiya, N. A compass that points to lupus regulatory factor-7 and its potential role in the transcription activation of interferon A genes. regulatory factor 7 and its association with IRF-3. defense. J. Interferon Cytokine Res. 2002, 22:59-71.
203. La Rocca, SA; Herbert, RJ; Crooke, H; Drew, TW; Wileman, TE; Powell, PP. Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J. Virol. 2005 79:7239-7247.
204. Lace, MJ; Anson, JR; Haugen, TH; Turek, LP. Interferon regulatory factor (IRF)-2 activates the HPV Virology. 2010, 399:270-279.
205. Lee, CH; Melchers, M; Wang, H; Torrey, TA; Slota, R; Qi, CF; Kim, JY; Lugar, P; Kong, HJ; Farrington, L; van der Zouwen, B; Zhou, JX; Lougaris, V; Lipsky, PE; Grammer, AC; Morse, HC 3rd. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein. J. Exp. Med. 2006, 203: 63-72.
206. Lefort, S; Soucy-Faulkner, A; Grandvaux, N; Flamand, L. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon J. Virol. 2007, 81:10950-10960.
207. Lei, X; Liu, X; Ma, Y; Sun; Yang, Y; Jin, Q; He, B; Wang, J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010 84:8051-8061.
208. Lei, X; Sun; Liu, X; Jin, Q; He, B; Wang, J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 2011, 85:8811-8818.
209. Levi, BZ; Hashmueli, S; Gleit-Kielmanowicz, M; Azriel, A; Meraro, D. ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J. Interferon Cytokine. Res. 2002, 22:153-160.
210. Levy, DE; Kessler, DS; Pine, R; Darnell, JE, Jr. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 1989, 3:1362-1371.
211. Levy, DE; Lew, DJ; Decker, T; Kessler, DS; Darnell, JE Jr. Synergistic interaction between interferon EMBO J. 1990 9:1105-1111.
212. Levy, DE; Garcia-Sastre, A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine. Growth Factor Rev. 2001, 12: 143-156.
213. Li, K; Foy, E; Ferreon, JC;Nakamura, M; Ferreon, AC; Ikeda, M; Ray, SC; Gale M Jr; Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-likereceptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA. 2005, 102:2992-2997.
214. Li, P; Wong, JJ; Sum, C; Sin, WX; Ng, KQ; Koh, MB; Chin, KC. IRF8 and IRF3 cooperatively regulate rapid interferon-ï induction in human blood monocytes. Blood. 2011, 117:2847-2854.
215. Liang, D; Gao, Y; Lin, X; He, Z; Zhao, Q; Deng, Q; Lan, K. A human herpesvirus mRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKe. Cell Res. 2011, 21:793-806.
216. Liang, Q; Deng, H; Li, X; Wu, X; Tang, Q; Chang, TH; Peng, H; Rauscher, FJ 3rd; Ozato, K; Zhu, F. Tripartite motif-containing protein 28 is a small ubiquitin-related modifier e3 ligase and negative regulator of IFN regulatory factor 7. J. Immunol. 2011, 187:4754-4763.
217. Liebermann, DA; Hoffman, B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Oncogene 2002, 21:3391-3402.
218. Lien, C; Fang, CM; Huso, D; Livak, F; Lu, R; Pitha, PM. Critical role of IRF-5 in regulation of B-cell differentiation. Proc. Natl. Acad. Sci. USA 2010, 107:4664-4668.
219. Lin, R; Mustafa, A; Nguyen, H; Gewert, D; Hiscott, J. Mutational analysis of interferon (IFN) regulatory factors 1 and 2;Effects on the induction of IFN-beta gene expression. J. Biol. Chem. 1994, 269:17542-17549.
220. Lin, R; Heylbroeck, C; Pitha, PM; Hiscott, J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential and proteasome-mediated degradation. Mol. Cell Biol. 1998, 18:2986-2996.
221. Lin, R; Hiscott, J. A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Mol. Cell Biochem. 1999a, 191169-180.
222. Lin, R; Mamane, Y; Hiscott, J. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell Biol. 1999b, 19: 2465-2474.
223. Lin, R; Heylbroeck, C; Genin, P; Pitha, PM; Hiscott, J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 1999c,19:959-966.
224. Lin, R; Genin, P; Mamane, Y; Hiscott, J. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cel.l Biol. 2000a, 20:6342-6353.
225. Lin, R., Mamane, Y., and Hiscott, J. Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 2000b, 275:34320-34327.
226. Lin, R; Genin, P; Mamane, Y; Sgarbanti, M; Battistini, A; Harrington, Jr WJ; Barber, GN; Hiscott, J. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 2001, 20:800-811.
227. Lin, R; Yang, L; Arguello, M; Penafuerte, C; Hiscott, J. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization J. Biol. Chem. 2005, 280:3088-3095.
228. Lin, R; Lacoste, J; Nakhaei, P; Sun, Q; Yang, L; Paz, S; Wilkinson, P; Julkunen, I; Vitour, D; Meurs, E; Hiscott, J. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis J. Virol. 2006, 80:6072-6083.
229. Liu, J; Ma X. Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1. J. Biol. Chem. 2006, 281:19188-19195.
230. Lohoff, M; Ferrick, D; Mittrucker, HW; Ducan, GS; Bischof, S; Rollinghoff, M; Mak, TW. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997, 6:681-689.
231. Lohoff, M; Duncan, GS; Ferrick, D; Mittrücker, HW; Bischof, S; Prechtl, S; Röllinghoff, M; Schmitt, E; Pahl, A; Mak, TW. Deficiency in the transcription J. Exp. Med. 2000, 192:325-336.
232. Lohoff, M; Mittrucker, HW; Prechtl, S; Bischof, S; Sommer, F; Kock, S; Ferrick, DA; Duncan, GS; Gessner, A; Mak, TW. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA. 2002, 99:11808-11812.
233. Lohoff, M; Mak, TW. Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. 2005, 5:125-133.
234. Lu, G; Reinert, JT; Pitha-Rowe, I; Okumura, A; Kellum, M; Knobeloch, KP; Hassel, B; Pitha, PM. ISG15 enhances the innate antiviral response Cell Mol. Biol. 2006, 52:29-34.
235. Lu, LL; Puri, M; Horvath, CM; Sen, GC. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J. Biol. Chem. 2008 283:14269-14276.
236. Lu, R. Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol. 2008, 29:487-492.
237. Lu, R; Pitha, PM. Monocyte differentiation to macrophage requires interferon regulatory factor 7. J. Biol.Chem. 2001, 276:45491-45496.
238. Lu, R; Medina, KL; Lancki, DW; Singh, H IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 2003, 17:1703-1708.
239. Luo, W; Skalnik, DG. Interferon regulatory factor-2 directs transcription from the gp91(phox) promoter. J. Biol. Chem. 1996, 271:23445-23451.
240. Ma, S; Turetsky, A; Trinh, L; Lu, R. IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development. J. Immunol. 2006, 177:7898-7904.
241. Ma, S; Pathak, S; Trinh, L; Lu, R. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood. 2008, 111, 1396-1403.
242. Magalhaes, JG; Sorbara, MT; Girardin, SE; Philpott, DJ. What is new with Nods? Current Opin. Immunol. 2011, 23:29-34.
243. Maiwald, T; Schneider, A; Busch, H; Sahle, S; Gretz, N; Weiss, TS; Kummer, U; Klingmüller, U. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon a-induced early antiviral signalling. FEBS J. 2010 277:4741-4754.
244. Malynn, BA; Ma, A. Ubiquitin makes its mark on immune regulation Immunity. 2010, 33:843-852.
245. Mancl, ME; Hu, G; Sangster-Guity, N; Olshalsky, SL; Hoops, K; Fitzgerald-Bocarsly, P; Pitha, PM; Pinder, K; Barnes, BJ. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 2005, 280: 21078-21090.
246. Marecki, S; Atchison, ML; Fenton, MJ. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. J. Immunol. 1999, 163:2713-2722.
247. Marecki, S; Fenton, MJ. The role of IRF-4 in transcriptional regulation. J. Interferon Cytokine. Res. 2002, 22:121-133.
248. Marecki, S; Riendeau, CJ; Liang, MD; Fenton, MJ. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J. Immunol. 2001, 166:6829-6838.
249. Marié, I; Durbin, JE; Levy, DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 1998, 17:6660-6669.
250. Martínez-Sobrido, L; Giannakas, P; Cubitt, B; García-Sastre, A. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol. 2007, 81:12696-12703.
251. Maruyama, S; Sumita, K; Shen, H; Kanoh, M; Xu, X; Sato, M; Matsumoto, M; Shinomiya, H; Asano, Y. Identification of IFN regulatory factor-1 binding site in IL-12 p40 gene promoter. J. Immunol. 2003, 170:997-1001.
252. Masumi, A; Wang, IM; Lefebvre, B; Yang, XJ; Nakatani, Y; Ozato K. The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol. Cell. Biol. 1999, 19:1810-1820.
253. Masumi, A; Ozato, K. Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment. J. Biol. Chem. 2001, 276:20973-20980.
254. Masumi, A; Tamaoki, S; Wang, IM; Ozato, K; Komuro, K. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett. 2002, 531:348-353.
255. Masumi, A; Yamakawa, Y; Fukazawa, H; Ozato, K; Komuro, K. Interferon regulatory factor-2 regulates cell growth J. Biol. Chem. 2003 278:25401-25407.
256. Matsuyama, T; Kimura, T; Kitagawa, M; Pfeffer, K; Kawakami, T; Watanabe, N; Kündig, TM; Amakawa, R; Kishihara, K; Wakeham, A; et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 1993 75:83-97.
257. Melroe, GT; Silva, L; Schaffer, PA; Knipe, DM. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-β induction. Virology 2007, 360:305-321.
258. Mempel, M; Voelcker, V; Köllisch, G; Plank, C; Rad, R; Gerhard, M; Schnopp, C; Fraunberger, P; Walli, AK; Ring, J; Abeck, D; Ollert, M. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J. Invest. Dermatol. 2003, 121:1389-1396.
259. Meraro, D; Hashmueli, S; Koren, B; Azriel, A; Oumard, A; Kirchhoff, S; Hauser, H; Nagulapalli, S; Atchison, ML; Levi, BZ. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors. J. Immunol. 1999, 163:6468-6478.
260. Meraro, D; Gleit-Kielmanowicz, M; Hauser, H; Levi, BZ. IFN J. Immunol. 2002, 168:6224-6231.
261. Meroni, G; Diez-Roux, G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. BioEssays 2005, 27:1147-1157.
262. Meylan, E; Curran, J; Hofmann, K; Moradpour, D; Binder, M; Bartenschlager, R; Tschopp, J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis. Nature. 2005, 437:1167-1172.
263. Meylan, E; Tschopp, J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell. 2006, 22:561-569.
264. Mibayashi, M; Martínez-Sobrido, L; Loo, YM; Cárdenas, WB; Gale, M Jr; García-Sastre, A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 2007, 81:514-524.
265. Miller, DM; Zhang, Y; Rahill, BM; Waldman, WJ; Sedmak, DD. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J. Immunol. 1999, 162: 6107-6113.
266. Mittrücker, HW; Matsuyama, T; Grossman, A; Kündig, TM; Potter, J; Shahinian, A; Wakeham, A; Patterson, B; Ohashi, PS; Mak, TW. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 1997, 275:540-543.
267. Miyamoto, M; Fujita, T; Kimura, Y; Maruyama, M; Harada, H; Sudo, Y; Miyata, T; Taniguchi, T. Regulated expression of a gene encoding Cell. 1988, 54:903-913.
268. Mizutani, T; Tsuji, K; Ebihara, Y; Taki, S; Ohba, Y; Taniguchi, T; Honda, K. Homeostatic erythropoiesis by the transcription factor IRF2 through attenuation of type I interferon signaling. Exp. Hematol. 2008, 36:255-264.
269. Moretti, F; Marinari, B; Lo Iacono, N; Botti, E; Giunta, A; Spallone, G; Garaffo, G; Vernersson-Lindahl, E; Merlo, G; Mills, AA; Ballarò, C; Alemà, S; Chimenti, S; Guerrini, L; Costanzo, A. A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias. J. Clin. Invest. 2010, 120:1570-1577.
270. Mori, M; Yoneyama, M; Ito, T; Takahashi, K; Inagaki, F; Fujita, T. Identification of Ser-386 of interferon regulatory factor 3 as critical target for inducible phosphorylation that determines activation. J. Biol. Chem. 2004, 279:9698-9702.
271. Morrow, AN; Schmeisser, H; Tsuno, T; Zoon, KC. A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells. J. Immunol. 2011, 186:1685-1693.
272. Muto, V; Stellacci, E; Lamberti, AG; Perrotti, E; Carrabba, A; Matera, G; Sgarbanti, M; Battistini, A; Liberto, MC; Focà, A. Human papillomavirus type 16 E5 protein induces expression of beta interferon J. Virol. 2011, 85:5070-5080.
273. Mutocheluh, M; Hindle, L; Areste, C; Chanas, SA; Butler, LM; Lowry, K; Shah, K; Evans, DJ; Blackbourn, DJ. Kaposi's sarcoma-associated herpesvirus viral interferon J. Gen. Virol. 2011, 92:2394-2398.
274. Nakagawa, K; Yokosawa, H. Degradation of transcription factor IRF-1 by the ubiquitinproteasome pathway. The C-terminal region governs the protein stability. Eur J. Biochem. 2000, 267:1680-1686.
275. Nakagawa, K.; Yokosawa, H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF1, FEBS Lett. 2002, 530:204-208.
276. Nakaya, T; Sato, M; Hata, N; Asagiri, M; Suemori, H; Noguchi, S; Tanaka, N; Taniguchi. T. Gene induction pathways mediated by distinct IRFs during viral infection. Biochem. Biophys. Res. Commun. 2001, 283: 1150-1156.
277. Narayan, V; Pion, E; Landré, V; Müller, P; Ball, KL. Docking-dependent ubiquitination of the interferon J. Biol. Chem. 2011, 286:607-611.
278. Negishi, H; Ohba, Y; Yanai, H; Takaoka, A; Honma, K; Yui, K; Matsuyama, T; Taniguchi, T; Honda, K. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 2005, 102:15989-15994.
279. Negishi, H; Fujita, Y; Yanai, H; Sakaguchi, S; Ouyang, X; Shinohara, M; Takayanagi, H; Ohba, Y; Taniguchi, T; Honda, K. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. USA 2006, 103:15136-15141.
280. Nehyba, J; Hrdlicková, R; Bose, HR. Dynamic evolution of immune system regulators: the history of the interferon regulatory factor family. Mol. Biol. Evol. 2009, 26:2539-2550.
281. Nelson, N; Kanno, Y; Hong, C; Contursi, C; Fujita, T; Fowlkes, BJ; O'Connell, E; Hu-Li, J; Paul, WE; Jankovic, D; Sher, AF; Coligan, JE; Thornton, A; Appella, E; Yang, Y; Ozato, K. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J. Immunol. 1996, 156:3711-3720.
282. Nelson, N; Marks, MS; Driggers, PH; Ozato, K. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell Biol. 1993, 13:588-599.
283. Ng, SL; Friedman, BA; Schmid, S; Gertz, J; Myers, RM; Tenoever, BR; Maniatis, T. IκB kinase (IKK) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. USA 2011, 108:21170-21175.
284. Nguyen, H; Hiscott, J; Pitha, PM. The growing family of interferon Cytokine. Growth Factor Rev. 1997, 8:293-312.
285. Nhu, QM; Cuesta, N; Vogel, SN. Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR J. Endotoxin. Res. 2006, 12:285-295.
286. Ning, S; Pagano, JS; Barber, GN. IRF7: activation, regulation, modification and function. Genes. Immun. 2011, 12:399-414. doi: 10.1038/gene.2011.21
287. O'Neill, LA; Bowie, AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat. Rev. Immunol. 2007, 7:353-364.
288. Okumura, A; Alce, T; Lubyova, B; Ezelle, H; Strebel, K; Pitha, PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 2008, 373:85-97.
289. Oshima, S; Nakamura, T; Namiki, S; Okada, E; Tsuchiya, K; Okamoto, R; Yamazaki, M; Yokota, T; Aida, M; Yamaguchi, Y; Kanai, T; Handa, H; Watanabe, M. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression Mol Cell Biol. 2004, 24:6298-6310.
290. Osterlund, PI; Pietilä, TE; Veckman, V; Kotenko, SV; Julkunen, I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. Immunol. 2007, 179:3434-3442.
291. Otsuka, M; Kato, N; Moriyama, M; Taniguchi, H; Wang, Y; Dharel, N; Kawabe, T; Omata, M. Interaction between the HCV NS3 protein and the host Hepatology. 2005, 41:1004-1012.
292. Ouyang, X; Negishi, H; Takeda, R; Fujita, Y; Taniguchi, T; Honda, K. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem. Biophys. Res. Commun. 2007, 354:1045-1051.
293. Ouyang, X; Zhang, R; Yang, J; Li, Q; Qin, L; Zhu, C; Liu, J; Ning, H; Shin, MS; Gupta, M; Qi, CF; He, JC; Lira, SA; Morse, HC 3rd; Ozato, K; Mayer, L; Xiong, H. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat. Commun. 2011, 2:314.
294. Ozato, K; Tailor, P; Kubota, T. The interferon regulatory factor family in host defense: mechanism of action. J. Biol. Chem. 2007, 282:20065-20069.
295. Pandey, AK; Yang, Y; Jiang, Z; Fortune, SM; Coulombe, F; Fitzgerald, KA; Sassetti, CM; Kelliher, MA. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 2009, 5:e1000500.
296. Panne, D; McWhirter, SM; Maniatis, T; Harrison, SC. Interferon response factor 3 is regulated by a dual phosphorylation dependent switch. J. Biol. Chem. 2007, 282:22816-22822.
297. Park, JS; Kim, EJ; Kwon, HJ; Hwang, ES; Namkoong, SE; Um, SJ. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 2000, 275:6764-6769.
298. Park, SM; Chae, M; Kim, BK; Seo, T; Jang, IS; Choi, JS; Kim, IC; Lee, JH; Park, J. SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2. Biochem. Biophys. Res. Commun. 2010, 391:926-930.
299. Passioura, T; Shen, S; Symonds, G; Dolnikov, A. A retroviral library genetic screen identifies IRF-2 as an inhibitor Oncogene. 2005, 24:7327-7336.
300. Pathak, S; Ma, S; Trinh, L; Lu, R. A role for interferon regulatory factor 4 in in receptor editing. Mol. Cell Biol. 2008, 28:2815-2824.
301. Paun, A; Pitha, PM. The IRF family, revisited. Biochimie 2007, 89:744-753.
302. Paun A, Reinert JT, Jiang Z, Medin C, Balkhi MY, Fitzgerald KA, Pitha PM (2008) Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J. Biol. Chem. 2008, 283:14295-14308.
303. Paun, A; Reinert, JT; Jiang, Z; Medin; Balkhi, M; Fitzgerald, KA; Pitha, PM. Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J. Biol. Chem. 2008, 283: 14295-14308.
304. Paun, A; Bankoti, R; Joshi, T; Pitha, PM; Stäger, S. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 2011, 7:e1001246.
305. Penninger, JM; Sirard, C; Mittrücker, HW; Chidgey, A; Kozieradzki, I; Nghiem, M; Hakem, A; Kimura, T; Timms, E; Boyd, R; Taniguchi, T; Matsuyama, T; Mak, TW. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity. 1997, 7:243-254.
306. Peters, A, Lee, Y, Kuchroo, VK. The many faces of Th17 cells. Trends Immunol. 2011, 32:395-401.
307. Pett, MR; Herdman, MT; Palmer, RD; Yeo, GS; Shivji, MK; Stanley, MA; Coleman, N. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. U S A 2006, 103:3822-3827.
308. Pietilä, TE; Veckman, V; Lehtonen, A; Lin, R; Hiscott, J; Julkunen, I. Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells. J. Immunol. 2007, 178:253-261.
309. Pine, R; Decker, T; Kessler, DS; Levy, DE; Darnel, JE Jr. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 1990, 10:2448-2457.
310. Pine, R. Constitutive expression of an ISGF2/IRF1 transgene J. Virol. 1992, 66:4470-4478.
311. Pion, E; Narayan, V; Eckert, M; Ball, KL. Role of the IRF-1 enhancer domain in signalling polyubiquitination and degradation. Cell Signal. 2009, 21:1479-1487.
312. Pivarcsi, A; Bodai, L; Réthi, B; Kenderessy-Szabó, A; Koreck, A; Széll, M; Beer, Z; Bata-Csörgoo, Z; Magócsi, M; Rajnavölgyi, E; Dobozy, A; Kemény, L. Expression and function of Toll-like receptors Int. Immunol. 2003, 15:721-730.
313. Platanias, LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat. Rev. Immunol 2005, 5:375-386.
314. Poltorak, A; He, X; Smirnova, I; Liu, M.Y; Van Huffel, C; Du, X; Birdwell, D; Alejos. E; Silva. M; Galanos, C; Freudenberg, M; Ricciardi-Castagnoli, P; Layton, B; Beutler, B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998, 282:2085-2088.
315. Praefcke, GJ; Hofmann, K; Dohmen, RJ. SUMO playing tag with ubiquitin. Trends Biochem. Sci. 2012, 37:23-31. Epub 2011 Oct 20.
316. Prakash, A; Levy, DE. Regulation of IRF7 through cell typespecific protein stability. Biochem Biophys. Res. Commun. 2006, 342:50-56.
317. Prins, KC; Cardenas, WB; Basler, CF. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 2009, 83: 3069-3077.
318. Qin, BY; Liu, C; Lam, SS; Srinath, H; Delston, R; Correia, JJ; Derynck, R; Lin, K. Crystal structure of IRF-3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 2003, 10:913-921.
319. Ramos, HJ; Gale, M Jr. RIG-I Like receptors Curr. Opin. Virol. 2011, 1:167-176.
320. Rehli, M; Poltorak, A; Schwarzfischer, L; Krause, SW; Andreesen, R; Beutler, B. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 2000, 275:9773-9781.
321. Remoli, AL; Marsili, G; Perrotti, E; Gallerani, E; Ilari, R; Nappi, F; Cafaro, A; Ensoli, B; Gavioli, R; Battistini, A. Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. Biochem. J. 2006, 396:371-380.
322. Rengarajan, J; Mowen, KA; McBride, KD; Smith, ED; Singh, ED; Glimcher, LH. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med. 2002, 95:1003-1012
323. Restivo, G; Nguyen, BC; Dziunycz, P; Ristorcelli, E; Ryan, RJ; Özuysal, ÖY; Di Piazza, M; Radtke, F; Dixon, MJ; Hofbauer, GF; Lefort, K; Dotto, GP. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes. EMBO J. 2011, 30:4571-4585.
324. Richardson, RJ; Dixon, J; Malhotra, S; Hardman, MJ; Knowles, L; Boot-Handford, RP; Shore, P; Whitmarsh, A; Dixon, MJ. Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat. Genet. 2006, 38:1329-1334.
325. Richez, C; Yasuda, K; Watkins, AA; Akira, S; Lafyatis, R; van Seventer, JM; Rifkin, IR. TLR4 J. Immunol. 2009, 182:820-828.
326. Robinson, MJ; Sancho, D; Slack, EC; LeibundGut-Landmann, S; Reis e Sousa, C; Rouyez, MC; Lestingi, M; Charon, M; Fichelson, S; Buzyn, A; Dusanter-Fourt, I. IFN J. Immunol. 2005, 174:3948-3958.
327. Robinson, MJ. Myeloid C-type lectins in innate immunity. Nat. Immunol. 2006, 7:1258-1265.
328. Romieu-Mourez, R; Solis, M; Nardin, A; Goubau, D; Baron-Bodo, V; Lin, R; Massie, B; Salcedo, M; Hiscott, J. Distinct roles for IFN regulatory factor (IRF)-3 and IRF-7 in the activation of antitumor properties of human macrophages. Cancer Res. 2006, 66:10576-10585.
329. Ronco, LV; Karpova, AY; Vidal, M; Howley, PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes. Dev. 1998, 12:2061-2072.
330. Ruffner, H; Reis, LF; Näf, D; Weissmann, C. Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc. Natl. Acad. Sci. U S A. 1993, 90:11503-11507.
331. Sabbah, A; Chang, TH; Harnack, R; Frohlich, V; Tominaga, K; Dube, PH; Xiang, Y; Bose, S. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 2009, 10:1073-1080.
332. Saira, K; Zhou, Y; Jones, C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits ï interferon promoter activity. J. Virol. 2007, 81:3077-3086.
333. Saito, M; Gao, J; Basso, K; Kitagawa, Y; Smith, PM; Bhagat, G; Pernis, A; Pasqualucci, L; Dalla-Favera, R. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterationsin B cell lymphoma. Cancer Cell. 2007, 12, 280-292.
334. Saitoh, T; Tun-Kyi, A; Ryo, A; Yamamoto, M; Finn, G; Fujita, T; Akira, S; Yamamoto, N; Lu, K.P; and Yamaoka, S. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 2006, 7:598-605.
335. Sakaguchi, S; Negishi, H; Asagiri, M; Nakajima, C; Mizutani, T; Takaoka, A; Honda, K; Taniguchi, T. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem. Biophys. Res. Commun. 2003, 306:860-866.
336. Salkowski, CA, Kopydlowski, K, Blanco, J, Cody, MJ, McNally, R, Vogel, SN. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 1999, 163:1529-1536.
337. Samarajiwa, SA; Forster, S; Auchettl, K; Hertzog, PJ. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 2009, 37(Database issue):D852-7.
338. Sansonetti, PJ. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 2006 Dec;7(12):1237-42.
339. Sato, M; Hata, N; Asagiri, M; Nakaya, T; Taniguchi, T; Tanaka, N. Positive feedback regulation of type I IFN FEBS Lett. 1998a; 441:106-109.
340. Sato, M; Tanaka, N; Hata, N; Oda, E; Taniguchi, T. Involvement of the IRF family transcription FEBS Lett. 1998b, 425:112-116.
341. Sato, M; Suemori, H; Hata, N; Asagiri, M; Ogasawara, K; Nakao, K; Nakaya, T; Katsuki, M; Noguchi, S; Tanaka, N; Taniguchi, T. Distinct and essential roles of transcription Immunity. 2000, 13:539-548.
342. Sato, T; Onai, N; Yoshihara, H; Arai, F; Suda, T; Ohteki, T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat. Med. 2009, 15:696-700.
343. Satoh, T; Takeuchi, O; Vandenbon, A; Yasuda, K; Tanaka, Y; Kumagai, Y; Miyake, T; Matsushita, K; Okazaki, T; Saitoh, T; Honma, K; Matsuyama, T; Yui, K; Tsujimura, T; Standley, DM; Nakanishi, K; Nakai, K; Akira, S. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 2010, 11: 936-944.
344. Savitsky, D; Tamura, T; Yanai, H; Taniguchi, T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 2010, 59:489-510.
345. Savitsky, DA; Yanai, H; Tamura, T; Taniguchi, T; Honda, K. Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proc. Natl. Acad. Sci. U S A. 2010, 107:10154-10159.
346. Schiavoni, G; Mattei, F; Sestili, P; Borghi, P; Venditti, M; Morse, III HC; Belardelli, F; Gabriele, L. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8α+ dendritic cells. J.Exp. Med. 2002, 196:1415-1425.
347. Schindler, C; Fu, XY; Improta, T; Aebersold, R; Darnell, JE Jr. Proc. Natl. Acad. Sci. USA. 1992, 89:7836-7839.
348. Schmid, S; Mordstein, M; Kochs, G; García-Sastre, A; Tenoever, BR. Transcription factor redundancy ensures induction of the antiviral state. J. Biol. Chem. 2010, 285:42013-42022.
349. Schmidt, M; Nagel, S; Proba, J; Thiede, C; Ritter, M; Waring, JF; Rosenbauer, F; Huhn, D; Wittig, B; Horak, I; Neubauer, A. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood. 1998; 91: 22-29.
350. Schmitz, F; Heit, A; Guggemoos, S; Krug, A; Mages, J; Schiemann, M; Adler, H; Drexler, I, Haas, T, Lang, R, Wagner, H. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN Eur. J. Immunol. 2007, 37:315-327.
351. Schoenemeyer, A; Barnes, BJ; Mancl, ME; Latz, E; Goutagny, N; Pitha, PM; Fitzgerald, KA; Golenbock, DT. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J. Biol. Chem. 2005, 280:17005-17012.
352. Schoggins, JW; Wilson, SJ; Panis, M; Murphy, MY; Jones, CT; Bieniasz, P; Rice, CM. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011, 472:481-485.
353. Schroder, K; Lichtinger, M; Irvine, KM; Brion, K; Trieu, A; Ross, IL; Ravasi, T; Stacey, KJ; Rehli, M; Hume, DA; Sweet, MJ. PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages. J. Leukoc. Biol. 2007, 81:1577-1590.
354. Schroder, K; Tschopp, J. The inflammasomes. Cell 2010, 140:821-832.
355. Schroder, M; Baran, M; Bowie, AG. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 2008, 27:2147-2157.
356. Sciammas, R; Davis, MM. Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation. J. Immunol. 2004, 172, 5427-5440.
357. Sciammas, R; Shaffer, AL; Schatz, JH; Zhao, H; Staudt, LM; Singh, H. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 2006, 25, 225-236.
358. Sen, N; Sommer, M; Che, X; White, K; Ruyechan, WT; Arvin, AM. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J. Virol. 2010, 84:9240-9253.
359. Seth, RB; Sun, L; Ea, CK; Chen, ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 2005, 122:669-682.
360. Seth, RB; Sun, L; Chen, ZJ. Antiviral innate immunity pathways. Cell Res. 2006, 16:141-147.
361. Sgarbanti, M; Borsetti, A; Moscufo, N; Bellocchi, MC; Ridolfi, B; Nappi, F; Marsili, G; Marziali, G; Coccia, EM; Ensoli, B; Battistini, A. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J. Exp. Med. 2002, 195:1359-1370.
362. Sgarbanti, M; Marsili, G; Remoli, AL; Orsatti, R; Battistini A. IRF-7: new role in the regulation of genes involved in adaptive immunity. Ann. N Y Acad. Sci. 2007, 1095:325-333.
363. Sgarbanti, M; Remoli, AL; Marsili, G; Ridolfi, B; Borsetti, A; Perrotti, E; Orsatti, R; Ilari, R; Sernicola, L; Stellacci, E; Ensoli, B; Battistini, A. IRF-1 is required for full NF-κB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J. Virol. 2008, 82: 3632-3641.
364. Sharf, R; Meraro, D; Azriel, A; Thornton, AM; Ozato, K; Petricoin, EF; Larner, AC; Schaper, F; Hauser, H; Levi, BZ. Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J. Biol. Chem. 1997, Apr 11;272(15):9785-9792.
365. Sharma, S; tenOever, BR; Grandvaux, N; Zhou, GP; Lin, R; Hiscott, J. Triggering the interferon antiviral response through an IKK-related pathway. Science. 2003, 300:1148-1151.
366. Shortman, K; Liu, YJ. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002, 2:151-161.
367. Solis, M; Nakhaei, P; Jalalirad, M. RIG-I-mediated antiviral signaling is inhibited in HIV J. Virol. 2011, 85:1224-1236.
368. Song, YJ; Izumi, KM; Shinners, NP; Gewurz, BE; Kie, VE. IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proc. Natl. Acad. Sci. USA 2008, 105:18448-18453.
369. Staal, A; Enserink, JM; Stein, JL; Stein, GS; van Wijnen, A. J. Molecular characterization of celtix-1, a bromo domain protein interacting with the transcription factor interferon regulatory factor 2. J. Cell Physiol. 2000, 185: 269-279.
370. Stellacci, E; Testa, U; Petrucci, E; Benedetti, E; Orsatti, R; Feccia, T; Stafsnes, M; Coccia, EM.; Marziali, G; Battistini, A. Interferon regulatory factor-2 drives megakaryocytic differentiation. Biochem J. 2004, 377:367-378.
371. Stetson, DB; Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24:93-103.
372. Stetson, DB; Ko, JS; Heidmann, T; Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
373. Stirnweiss, A; Ksienzyk, A; Klages, K; Rand, U; Grashoff, M; Hauser, H; Kröger, A. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through Viperin gene induction. J. Immunol. 2010, 184:5179-5185.
374. Stockinger, S; Reutterer, B; Schaljo, B; Schellack, C; Brunner, S; Materna, T; Yamamoto, M; Akira, S; Taniguchi, T; Murray, PJ; Mu ller, M; Decker, T. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR-and Nod2-independent mechanism. J. Immunol. 2004, 173:7416-7425.
375. Su, ZZ; Sarkar, D; Emdad, L; Barral, PM; Fisher, PB. Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression. J. Cell Physiol. 2007, 213:502-510.
376. Suhara, W; Yoneyama, M; Fujita, T. Direct Involvement of CREB-binding Protein/p300 in Sequence-specific DNA Binding of Virus-activated Interferon Regulatory Factor-3 Holocomplex. J. Biol. Chem. 2002, 277:22304-22313.
377. Suzuki, S; Honma, K; Matsuyama, T; Suzuki, K; Toriyama, K; Akitoyo, I; Yamamoto, K; Suematsu, T; Nakamura, M; Yui, K; Kumatori A. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha-dendritic cell development. Proc. Natl. Acad. Sci. USA 2004, 101:8981-8986.
378. Tabeta, K; Georgel, P; Janssen, E; Du, X; Hoebe, K; Crozat, K; Mudd, S; Shamel, L; Sovath, S; Goode, J; Alexopoulou, L; Flavell, RA; Beutler, B. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2004, 101:3516-3521.
379. Tailor, P; Tamura, T; Kong, HJ; Kubota, T; Kubota, M; Borghi, P; Gabriele, L; Ozato K. The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. Immunity 2007, 27:228-239.
380. Tailor, P; Tamura, T; Morse, HC 3rd; Ozato, K. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 2008, 111:1942-1945.
381. Takaoka, A; Yanai, H; Kondo, S; Duncan, G; Negishi, H; Mizutani, T; Kano, S; Honda, K; Ohba, Y; Mak, TW; Taniguchi T. Integral role of IRF-5 in the gene induction Nature. 2005, 434:243-249.
382. Takaoka, A; Wang, Z; Choi, MK; Yanai, H; Negishi, H; Ban, T; Lu, Y; Miyagishi, M; Kodama, T; Honda, K; Ohba, Y; Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007, 448:501-505.
383. Takaoka, A; Tamura, T; Taniguchi, T. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 2008, 99:467-478.
384. Takeuchi, O; Akira, S. Pattern recognition receptors and inflammation. Cell. 2010, 140:805-820.
385. Taki, S; Sato, T; Ogasawara, K; Fukuda, T; Sato, M; Hida, S; Suzuki, G; Mitsuyama, M; Shin, EH; Kojima, S; Taniguchi, T; Asano, Y. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 1997, 6:673-679.
386. Taki, S; Nakajima, S; Ichikawa, E; Saito, T; Hida, S. IFN J. Immunol. 2005, 174:6005-6012.
387. Tamura, T; Nagamura-Inoue, T; Shmeltzer, Z; Kuwata, T; Ozato, K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 2000, 13:155-165.
388. Tamura, T; Tailor, P; Yamaoka, K; Kong, HJ; Tsujimura, H; O'Shea, JJ; Singh, H; Ozato, K. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 2005a, 174:2573-2581.
389. Tamura, T; Thotakura, P; Tanaka, TS; Ko, MS; Ozato, K. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood. 2005b, 106:1938-1947.
390. Tanaka, N; Kawakami, T; Taniguchi, T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell Biol. 1993, 13:4531-4538.
391. Tang, X; Gao, JS; Guan, YJ; McLane, KE; Yuan, ZL; Ramratnam, B; Chin, YE. Acetylation-dependent signal transduction for type I interferon receptor. Cell. 2007, 131:93-105.
392. Taniguchi, T; Ogasawara K; Takaoka A; Tanaka N. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 2001, 19:623-655.
393. tenOever, BR; Sharma, S; Zou, W; Sun, Q; Grandvaux, N; Julkunen, I;Hemmi, H; Yamamoto, M; Akira, S; Yeh, WC; Lin, R; and Hiscott, J. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 2004, 78:10636-10649.
394. Testa, U; Stellacci, E; Pelosi, E; Sestili, P; Venditti, M; Orsatti, R; Fragale, A; Petrucci, E; Pasquini, L; Belardelli, F; Gabriele, L; Battistini, A. Impaired myelopoiesis in mice devoid of interferon regulatory factor 1. Leukemia. 2004, 18:1864-1871.
395. Thanos, D; Maniatis, T. Virus induction Cell 1995, 83:1091-100.
396. Thefilopoulos, AN; Baccala, R; Bautler, B; Kono, DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.
397. Thomason, HA; Zhou, H; Kouwenhoven, EN; Dotto, GP; Restivo, G; Nguyen, BC; Little, H; Dixon, MJ; van Bokhoven, H; Dixon, J. Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. J. Clin. Invest. 2010, 120:1561-1569. doi: 10.1172/JCI40266.
398. Thompson, EC; Cobb, BS; Sabbattini, P; Meixlsperger, S; Parelho, V; Liberg, D; Taylor, B; Dillon, N; Georgopoulos, K; Jumaa, H; Smale, ST; Fisher, AG; Merkenschlager, M. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity. 2007, 26:335-344.
399. Ting, JP; Duncan, JA; Lei, Y. How the noninflammasome NLRs function in the innate immune system. Science. 2010, 327:286-290.
400. Tokoyoda, K; Egawa, T; Sugiyama, T; Choi, BI; Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004, 20:707-718.
401. Tominaga, N; Ohkusu-Tsukada, K; Udono, H; Abe, R; Matsuyama, T; Yui, K. Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int. Immunol. 2003, 15:1-10.
402. Tsujimura, H; Nagamura-Inoue, T; Tamura, T; Ozato, K. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. J. Immunol. 2002, 169: 1261-1269.
403. Tsujimura, H; Tamura, T; Kong, HJ; Nishiyama, A;Ishii, KJ; Klinman, DM; Ozato, K Toll-like receptor 9 signaling activates NfkappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 2004, 172:6820-6827.
404. Tsujmura, H; Tamura, T; Ozato, K; Cuttin, E. IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type 1 IFN-producing plasmacytoid dendritic cells. J. Immunol. 2003, 170:1131-1135.
405. Turcotte, K; Gauthier, S; Tuite, A; Mullick, A; Malo, D; Gross, P. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloidleukemia-like syndrome in BXH-2 mice. J. Exp. Med. 2005, 201:881-890.
406. Uematsu, S; Akira, S. Toll-like receptors and Type I interferons. J Biol Chem 282: 15319-15323;
407. Bogdan C, Mattner J, Schleicher U (2004) The role of type I interferons in non-viral infections. Immunol. Rev. 2007, 202: 33-48.
408. Unterholzner, L; Bowie, AG. The interplay between viruses Biochem. Pharmacol. 2008, 75:589-602.
409. Unterholzner, L; Sumner, RP; Baran, M; Ren, H; Mansur, DS; Bourke, NM; Randow, F; Smith, GL; Bowie, AG. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog. 2011, 7:e1002247.
410. Unterstab, G; Ludwig, S; Anton, A; Planz, O; Dauber, B; Krappmann, D; Heins, G; Ehrhardt, C; Wolff, T. Viral targeting of the interferon-ï-inducing Traf family member-associated NFkB activator (TANK)-binding kinase-1. Proc. Natl. Acad. Sci. USA 2005, 102:13640-13645.
411. van't Wout AB, Lehrman GK, Mikheeva SA, O'Keeffe GC, Katze MG, Bumgarner RE, Geiss GK, Mullins JI. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J. Virol. 2003, 77:1392-1402.
412. Vaughan, PS; Aziz, F; van Wijnen, AJ; Wu, S; Harada, H; Taniguchi, T; Soprano, KJ; Stein, JL; Stein, GS. Activation of a cell cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature. 1995, 377:362-365.
413. Vaughan, PS; van der Meijden, CM; Aziz, F; Harada, H; Taniguchi, T; van Wijnen, AJ; Stein, JL; Stein, GS Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2. J. Biol. Chem. 1998, 273:194-199.
414. Veals, SA; Schindler, C; Leonard, D; Fu, XY; Aebersold, R; Darnell, JE; Jr., and Levy, DE. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell Biol. 1992, 12:3315-3324.
415. Veals, SA; Santa Maria, T; Levy, DE. Two domains of ISGF3 gamma that mediate protein-DNA Mol. Cell Biol. 1993, 13:196-206.
416. Wang, H; Lee, CH; Qi, C; Tailor, P; Feng, J; Abbasi, S; Atsumi, T; Morse, HC 3rd. IRF8 regulates B-cell lineage specification, commitment, and differentiation. Blood. 2008, 112: 4028-4038.
417. Wang, Y; Liu, DP; Chen, PP; Koeffler, HP; Tong, XJ; Xie, D. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res. 2007. 67: 2535-2543.
418. Wang, Z; Choi, MK; Ban, T; Yanai, H; Negishi, H; Lu, Y; Tamura, T; Takaoka, A; Nishikura, K; Taniguchi, T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNAsensing molecules. Proc. Natl. Acad. Sci. USA 2008, 105:5477-5482.
419. Watanabe, N; Sakakibara, J; Hovanessian, AG; Taniguchi, T; Fujita, T. Activation of IFN-beta element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res. 1991, 19:4421-4428.
420. Watanabe, T; Asano, N; Fichtner-Feigl, S; Gorelick, PL; Tsuji, Y; Matsumoto, Y; Chiba, T; Fuss, IJ; Kitani, A; Strober W: NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 2010, 120:1645-1662.
421. Wathelet, MG; Lin, CH; Parekh, BS; Ronco, LV; Howley, PM; Maniatis, T. Virus infection Mol. Cell. 1998, 1:507-518.
422. Weaver, BK; Kumar, KP; Reich, NC. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell Biol. 1998, 18:1359-1368.
423. Weaver, CT; Harrington, LE;, Mangan, PR; Gavrieli, M; Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006, 24:677-688.
424. White, LC; Wright, KL; Felix, NJ; Ruffner, H; Reis, LF; Pine, R; Ting, JP. Regulation of LMP2 and TAP1 genes Immunity 1996, 5:365-376.
425. Wies, E; Hahn, AS; Schmidt, K; Viebahn, C; Rohland, N; Lux, A; Schellhorn, T; Holzer, A; Jung, JU; Neipel, F. The Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J. Biol. Chem. 2009, 284:8525-8538.
426. Wilkins, C; Gale, M Jr. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 2010, 22:41-47.
427. Wilson, JR; de Sessions, PF; Leon, MA; Scholle, F. West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J. Virol. 2008, 82:8262-8271.
428. Xi, H; Eason, DD; Ghosh, D; Dovhey, S; Wright, KL; Blanck, G. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2. Oncogene. 1999, 43:5889-5903.
429. Xiong, H; Li, H; Kong, HJ; Chen, Y; Zhao, J; Xiong, S; Huang, B; Gu, H; Mayer, L; Ozato, K; Unkeless, JC. Ubiquitin-dependentdegradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression. J. Biol. Chem. 2005, 280: 23531-23539.
430. Xiong, H; Zhu, C; Li, H; Chen, F; Mayer, L; Ozato, K; Unkeless, JC; Plevy, SE. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J. Biol. Chem. 2003, 278, 2271-2277.
431. Xu, LG; Wang, YY; Han, KJ; Li, LY; Zhai, Z; Shu, HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell. 2005, 19:727-740.
432. Yamagata, T; Nishida, J; Tanaka, S; Sakai, R; Mitani, K; Yoshida, M; Taniguchi, T; Yazaki, Y; Hirai, H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol. Cell Biol. 1996, 16:1283-1294.
433. Yamamoto, H; Lamphier, MS; Fujita, T; Taniguchi, T; Harada, H. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene 1994, 9:1423-1428.
434. Yamamoto, M; Kato, T; Hotta, C; Nishiyama, A; Kurotaki, D; Yoshinari, M; Takami, M; Ichino, M; Nakazawa, M; Matsuyama, T; Kamijo, R; Kitagawa, S; Ozato, K; Tamura, T. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One. 2011, 6:e25812.
435. Yanai, H; Chen, HM; Inuzuka, T; Kondo, S; Mak, TW; Takaoka, A; Honda, K; Taniguchi, T. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc. Natl. Acad. Sci. USA 2007, 104:3402-3407.
436. Yang, H; Lin, CH; Ma, G; Baffi, MO; Wathelet, MG. Interferon regulatory factor-7 synergizes with other transcription J, Biol, Chem. 2003, 278:15495-15504.
437. Yang, Y; Liang, Y; Qu, L; Chen, Z; Yi, M; Li, K; Lemon, SM. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc, Natl, Acad,Sci, USA 2007, 104:7253-7258.
438. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT-1 dependent type I interferon-response genes. Nature Immunol. 2008, 9:378-387.
439. Yasuda, K; Richez, C; Maciaszek, JW; Agrawal, N; Akira, S; Marshak-Rothstein, A; Rifkin, IR. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J, Immunol. 2007, 178:6876-6885.
440. Yoneyama, M; Suhara, W; Fukuhara, Y; Sato, M; Ozato, K; Fujita, T. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J, Biochem. 1996, 120:160-169.
441. Yoneyama, M; Suhara, W; Fukuhara, Y; Fukada, M; Nishida, E; Fujita, T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 andCBP/p300. Embo, J. 1998, 17:1087-1095.
442. Yoneyama, M; Kikuchi, M; Natsukawa, T; Shinobu, N; Imaizumi, T; Miyagishi, M; Taira, K; Akira, S; Fujita, T. The RNA Nat. Immunol. 2004, 5:730-737.
443. Yoneyama, M; Kikuchi, M; Matsumoto, K; Imaizumi, T; Miyagishi, M; Taira, K; Foy, E; Loo, YM; Gale, M Jr;; Akira, S; Yonehara, S; Kato, A; Fujita, T. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity J. Immunol. 2005, 175:2851-2858
444. Yu, Y; Hayward, GS. The ubiquitin Immunity. 2010, 33:863-877.
445. Yu, Y; Wang, SE; Hayward, GS. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation Immunity 2005, 22:59.-70.
446. Zhang, L; Pagano, JS. IRF-7, a new interferon regulatory factor associated with Epstein-Barr Virus latency. Mol. Cell Biol. 1997, 17: 5748-5757.
447. Zhang, L; Zhang, J; Lambert, Q; Der, CJ; Del Valle, L; Miklossy, J; Khalili, K; Zhou, Y; Pagano, JS. Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J. Virol, 2004, 78:12987-12995.
448. Zhang, SY; Jouanguy, E; Ugolini, S; Smahi, A; Elain, G; Romero, P; Segal, D; Sancho-Shimizu, V; Lorenzo, L; Puel, A; Picard, C; Chapgier, A; Plancoulaine, S; Titeux, M; Cognet, C; von Bernuth, H; Ku, CL; Casrouge, A; Zhang, XX; Barreiro, L; Leonard, J; Hamilton, C; Lebon, P; Heron, B; Vallee, L; Quintana-Murci, L; Hovnanian, A; Rozenberg, F; Vivier, E; Geissmann, F; Tardieu, M; Abel, L; Casanova, JL. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007, 317:1522-1527.
449. Zhao, J; Kong, HJ; Li, H; Huang, B; Yang, M; Zhu, C; Bogunovic, M; Zheng, F; Mayer, L; Ozato, K; Unkeless, J; Xiong, H. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J, Biol, Chem. 2006, 281:10073-10080.
450. Zhao, T; Yang, L; Sun, Q; Arguello, M; Ballard, DW; Hiscott, J; Lin, R. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat, Immunol. 2007, 8:592-600.
451. Zhong, B; Yang, Y; Li, S; Wang, YY; Li, Y; Diao, F; Lei, C; He, X; Zhang, L; Tien, P; Shu, HB. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity. 2008, 29:538-550.
452. Zhou, JX; Lee, CH; Qi, CF; Wang, H; Naghashfar, Z; Abbasi S; Morse HC 3rd. IFN regulatory factor 8 regulates MDM2 in germinal center B cells. J. Immunol. 2009, 183:3188-3194.
453. Zhu, C; Saberwal, G; Ly, Y; Platanias, F; L. C. and Eklund E. A. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin. J, Biol, Chem. 2004, 279:50874-50885.
454. Zhu, FX; King, SM; Smith, EJ; Levy, DE; Yuan, YA. Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl, Acad. Sci. USA 2002, 99:5573-5578.